title: National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.
authors.affiliation: University of Nebraska Medical Center, Omaha, NE, USA.
authors.forename: Michael F
authors.initials: MF
authors.lastname: Sorrell
authors.forename: Edward A
authors.initials: EA
authors.lastname: Belongia
authors.forename: Jose
authors.initials: J
authors.lastname: Costa
authors.forename: Ilana F
authors.initials: IF
authors.lastname: Gareen
authors.forename: Jean L
authors.initials: JL
authors.lastname: Grem
authors.forename: John M
authors.initials: JM
authors.lastname: Inadomi
authors.forename: Earl R
authors.initials: ER
authors.lastname: Kern
authors.forename: James A
authors.initials: JA
authors.lastname: McHugh
authors.forename: Gloria M
authors.initials: GM
authors.lastname: Petersen
authors.forename: Michael F
authors.initials: MF
authors.lastname: Rein
authors.forename: Doris B
authors.initials: DB
authors.lastname: Strader
authors.forename: Hartwell T
authors.initials: HT
authors.lastname: Trotter
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D035843:Biomedical Research; D006528:Carcinoma, Hepatocellular / Q000821:virology; D014943:Global Health; D006509:Hepatitis B / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000821:virology; D008113:Liver Neoplasms / Q000821:virology; D015995:Prevalence; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents